Purpose Colorectal tumors (CRC) with microsatellite instability (MSI) show resistance to chemotherapy with 5-Xuorouracil (5-FU), the most widely used pharmacological drug for CRC treatment. The aims of this study were to test the ability of quercetin (Q) and luteolin (L) to increase the sensitivity of MSI CRC cells to 5-FU and characterize the dependence of the eVects on cells' p53 status. Methods Two MSI human CRC-derived cell lines were used: CO115 wild type (wt) for p53 and HCT15 that harbors a p53 mutation. Apoptosis induction in these cells by 5-FU, Q and L alone, and in combinations was evaluated by TUNEL and western blot. The dependence of the eVects on p53 was conWrmed by small interference RNA (siRNA) in CO115 cells and in MSI HCT116 wt and p53 knockout cells. Results CO115 p53-wt cells are more sensitive to 5-FU than the p53-mutated HCT15. The combination treatment of 5-FU with L and Q increased apoptosis with a signiWcant eVect for Q in CO115. Both Xavonoids increased p53 expression in both cell lines, an eVect particularly remarkable for Q. The signiWcant apoptotic enhancement in CO115 incubated with Q plus 5-FU involved the activation of the apoptotic mitochondrial pathway. Importantly, knockdown of p53 by siRNA in CO115 cells and p53 knockout in HCT116 cells totally abrogated apoptosis induction, demonstrating the dependence of the eVect on p53 modulation by Q. Conclusion This study suggests the potential applicability of these phytochemicals for enhancement 5-FU eYciency in MSI CRC therapy, especially Q in p53 wt tumors.
Introduction
Chemotherapy with 5-Xuorouracil (5-FU) is the basis for colorectal carcinoma (CRC) treatment, one important cause of cancer-related death in western societies [1] . However, signiWcant resistance to this drug has been reported [2] [3] [4] . To overcome resistance, drugs such as irinotecan and oxaliplatin are used in combination with 5-FU and have provided increased eYcacy although not in all patients [3, 5, 6] . Particularly, tumors with microsatellite instability (MSI) do not generally respond satisfactorily to 5-FU [7] [8] [9] [10] . MSI tumors, which occur in approximately 15% of sporadic CRC cases and in 90% of hereditary non-polyposis colorectal cancer (HNPCC), have mutations in the mismatch repair (MMR) genes, resulting in an inability to correct DNA replication errors and in the accumulation of mutations [8, 9, 11] . In vitro studies have also shown that DNA MMR deWciency may be responsible for tumor resistance to 5-FU [7, 8, 10] .
Previous studies have shown that, independently of MSI status, mutations in the gene P53 contribute to 5-FU resistance in CRC and have profound eVects on drug responses [12, 13] with reduced induction of apoptosis and inhibition of cell cycle [14, 15] . The prognosis in patients presenting MSI tumors with p53 mutations has been shown to be poorer compared with those having MSI tumors with p53 wild type [16] .
The induction of apoptosis by 5-FU may occur through p53 activation and both the intrinsic and extrinsic pathways with activation of caspases [17] . In the intrinsic pathway, Bcl-2 family proteins modulate mitochondrial membrane permeabilization, which leads to the release of cytochrome c and activation of caspase-9 that in turn activate the eVector caspase-3. Activation of death receptors on the cell membrane (extrinsic pathway), which subsequently activates caspase-8 and caspase-3, may also be induced by 5-FU [17] .
Dietary phytochemicals have been shown to induce apoptosis through the modulation of diVerent pathways contributing to decreased tumor malignance and chemoresistance [18] [19] [20] . In addition to eVects on mitochondrial and death receptor pathways, some proapoptotic eVects of natural compounds have also been attributed to c-Jun N-terminal kinase (JNK) and p38 stress-activated protein kinases [19, [21] [22] [23] .
In a previous study, we showed that two structurally related Xavonoids quercetin (Q; a Xavonol) and luteolin (L; a Xavone), commonly found in fruits and vegetables, have antiproliferative eVects in HCT15 (mutant KRAS) and CO115 (mutant BRAF) human CRC cells through the regulation of KRAS and both the MAPK/ERK and the PI3K pathways [24] . The anticarcinogenic eVects of these Xavonoids suggest the suitability of diet rich in Q and/or L for CRC patients undergoing treatment with 5-FU. In the present study, we tested the possible therapeutic eYcacy of Q and L in combination with the pharmaceutical drug 5-FU in a MSI p53 wild-type (wt) and a p53-mutant CRC cell lines, CO115 and HCT15, respectively [25, 26] . In addition, the mechanism of Q and L in inducing apoptosis in these MSI CRC cell lines was investigated and the dependence on p53 conWrmed by siRNA. Our data show the potential applicability of these Xavonoids for use in combination with 5-FU to induce apoptosis in CRC, particularly for Q in a p53 wt background.
Materials and methods

Reagents and antibodies
Quercetin (Q), z-VAD-fmk (zVAD), staurosporine (STS), 5-Xuorouracil (5-FU) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Luteolin (L) was purchased from Extrasynthese (Genay, France). Stock solutions of test compounds were made in dimethyl sulfoxide (DMSO), and aliquots were kept at ¡20°C. All other reagents and chemicals used were of analytical grade.
Primary antibodies were purchased from the following sources: anti-cleaved caspase-9 and anti-phospho-p38 MAPK (Thr180/Tyr182) from Cell Signaling (Danvers, MA, USA); anti-caspase-3 from Calbiochem (San Diego, CA); anti-Bcl-2, anti-Bax, anti-PARP-1, anti-phospho-JNK, anti-JNK, anti-p38 total and anti-p53 from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); and anti--actin from Sigma-Aldrich. Secondary antibodies HRP donkey anti-rabbit and sheep anti-mouse were purchased from GE Healthcare (Bucks, UK).
Cell lines HCT15 and CO115 human colon carcinoma-derived cell lines were kindly provided by Dr. Raquel Seruca (IPAT-IMUP, University of Porto, Portugal). The two isogenic HCT116 colon carcinoma, p53-wild-type (p53-wt) and p53 complete knockout for p53 (p53-null) cells, were kindly provided by Vogelstein [27] . The cell lines were maintained at 37°C in a humidiWed 5% CO 2 atmosphere in RPMI-1640 medium (Sigma-Aldrich) supplemented with 10 mM HEPES, 0.1 mM pyruvate, 1% antibiotic/antimycotic solution (Sigma-Aldrich), and 6% heat-inactivated fetal bovine serum (FBS; EU standard, Lonza, Verviers, Belgium).
Cell viability/proliferation assay
To investigate the eVects of 5-FU on cell viability/proliferation in HCT15 and CO115 cells, as well as the eVect of Q and 5-FU in the two isogenic HCT116 cell lines, the MTT reduction assay was used as described previously [24] . Cells were treated with diVerent concentrations of 5-FU and Q for 46 h and then for two more hours in the presence of MTT (Wnal concentration 0.5 mg/ml). Hydrogen chloride 0.04 M in isopropanol was then used to dissolve the formazan crystals. The number of viable cells in each well was estimated by the cell capacity to reduce MTT, using a spectrophotometer. The results were expressed as percentage relative to the control (cells without any test compound), and MTT reduction at the beginning of incubation (t = 0 h) was subtracted from all experimental conditions, including the control. Since the eVects of the compounds were studied in 48 h incubations and cells grow signiWcantly during this period, this treatment of the results allows to distinguish between signiWcant cell death (negative values) and inhibition of proliferation (values between 0 and 100%). The IC50 corresponds to the concentration that inhibits cell viability/proliferation by 50%. Results are presented as mean § SEM of at least three independent experiments. TUNEL assay TUNEL (TdT-mediated dUTP nick-end labeling) assay was performed to estimate the percentage of apoptotic cells treated for 48 h with diVerent concentrations of 5-FU alone and in combination with Q and L. In HCT15 and CO115 cell lines, the concentrations of Q and L used induce signiWcant inhibition of cell proliferation and cell viability without substantial severe and acute cell death, as determined by BrdU assay and MTT test in a previous study using the same cells and conditions [24] . Both cell lines were also treated with Q and L in combination with 20 M z-VAD-fmk (zVAD), a general caspase inhibitor, for 48 h, to assess the involvement of caspases activation in the apoptotic process induced by the test compounds. Staurosporine (STS) 0.25 M, an apoptosis inducer, was also used as a positive control. In HCT116 isogenic cell lines (p53 wt and p53-null) and CO115 cells depleted for p53 by small interference RNA (siRNA), the concentrations of 5-FU and Q used signiWcantly inhibited cell proliferation without substantial severe and acute cell death.
After treatments, cells were collected (both Xoating and attached cells), Wxed with 4% paraformaldehyde for 15 min at room temperature, and attached onto a polylysine-treated slide using a Shandon Cytospin. Cells were then washed in PBS and permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min on ice. TUNEL assay was performed using a kit from Roche (Mannheim, Germany), following the manufacturer's instructions. Hoechst was used for nuclei staining. The percentage of apoptotic cells was calculated from the ratio between TUNEL positive cells and total number of cells, from a count higher than 500 cells per slide under a Xuorescent microscope. Results are presented as mean § SEM of at least three independent experiments.
Western blot analysis
Cells were treated with Q, L, 5-FU, and STS alone and co-incubated with Q and 5-FU for 48 h, and total cell lysates were prepared to measure the expression of diVerent proteins. The cells were washed with PBS and lysed for 15 min at 4°C with ice-cold RIPA buVer (1% NP-40 in 150 mM NaCl, 50 mM Tris (pH 7.5), 2 mM EDTA), supplemented with 20 mM NaF, 1 mM phenylmethylsulfonyl Xuoride (PMSF), 20 mM Na 2 V 3 O 4 , and protease inhibitor cocktail (Roche, Mannheim, Germany). Protein concentration was quantiWed using a Bio-Rad DC protein assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and BSA used as a protein standard. To perform western blot analysis, 20 g of protein was resolved by SDS-polyacrylamide gel and then electroblotted onto a Hybond-P polyvinylidene diXuoride membrane (GE Healthcare). Membranes were blocked in TPBS (PBS with 0.05% Tween-20) containing 5% (w/v) non-fat dry milk or BSA (bovine serum albumin), washed in TPBS, and then incubated with primary antibody. After washing, membranes were incubated with secondary antibody conjugated with IgG horseradish peroxidase and immunoreactive bands were detected using the Immobilon solutions (Millipore, Billerica, MA, USA) under a chemiluminescence detection system, the Chemi Doc XRS (Bio-Rad Laboratories, Inc.). Band area intensity was quantiWed using the Quantity One software from Bio-Rad. -actin was used as loading control.
p53 knockdown in CO115 cells CO115 human colon cancer cells were transiently transfected with Oligofectamine (Invitrogen, Carlsbad, CA) and 100 nM of p53 siRNA in OPTI-MEN (Invitrogen) according to the manufacturer's instructions. The p53 siRNA target sequence was GUGGAGUAUUUGGAUGACA, which was purchased from Invitrogen. Control of siRNA experiments was included by using a siRNA against GFP. ConWrmation of p53 knockdown was done by western blot analysis. Twenty four hours after transfection, cells were incubated with 5-FU or Q alone and with both in combination, for 48 h, and apoptosis measured by the TUNEL assay.
Statistical analysis
Statistical analyses were done using t test, GraphPad Prism 4.0 software (San Diego, CA, USA). P values ·0.05 were considered statistically signiWcant.
Results
Colon cancer cells' sensitivity to 5-FU
The eVect of 5-FU on cell viability/proliferation and apoptosis in HCT15 and CO115 cells was established by the MTT and TUNEL assays, respectively. As shown in Fig. 1a , 5-FU was more eVective in decreasing cell viability/proliferation in CO115 than in HCT15 after 48 h treatment. The 5-FU concentrations that inhibit cell viability/ proliferation by 50% (IC50) are around 100 M in HCT15 and 1 M in CO115. The diVerences in susceptibility of the two cell lines to 5-FU were also observed for apoptosis, with HCT15 being more resistant to apoptosis compared to CO115 (Fig. 1b) . IC50 concentrations of 5-FU were selected for the next experiments (100 M for HCT15 and 1 M for CO115).
Combined eVect of 5-FU and test compounds on apoptosis
The induction of apoptosis in both cell lines treated with Q or L, at IC50 concentrations, as tested previously [24] , or 5-FU (IC50), was monitored by the TUNEL assay in both cell lines. As shown in Fig. 2 , the Xavonoids induced a higher percentage of apoptotic cells in CO115 when compared with HCT15. In HCT15 cells, L or Q in combination with 5-FU demonstrated an additive eVect on the induction of apoptosis, i.e., the eVects of the combination were similar to the sum of the eVects of Q and 5-FU when used alone (Fig. 2a) . In CO115 cells, L in combination with 5-FU showed an additive eVect in apoptosis induction, whereas Q demonstrated to signiWcantly potentiate the induction of apoptotic cell death when combined with 5-FU (Fig. 2b) . In all cases, the eVects on apoptosis of co-incubations were higher than 5-FU alone or test compound alone.
EVects of Q, L, and 5-FU on markers of pathways related with apoptosis In order to determine the role of caspase activation on the apoptotic eVects of the test compounds, the caspase inhibitor zVAD was used and apoptosis measured by TUNEL assay. Apoptosis induced by the test compounds, Q and L, and STS, the apoptosis inducer, was inhibited by zVAD in CO115 (Fig. 3b) but not in HCT15 (Fig. 3a) . In addition, as shown in Fig. 3c , none of the compounds induced cleaved (active) caspase-9 in HCT15 cells and only STS induced cleavage of caspase-3 (active form) and of PARP (inactive form). On the other hand, in CO115, cleaved caspase-9 and caspase-3 were observed with all compounds as well as cleavage of PARP and/or a remarkable decreased of uncleaved PARP (active form).
To further elucidate the apoptotic eVects of the test compounds and 5-FU, the expression of the positive mediators of apoptosis, p53 and Bax, as well as the negative regulator, Bcl-2, was analyzed by western blot (Fig. 4a) . It was observed that Q, L, and 5-FU induced p53 levels in both cell lines. Levels of Bcl-2 were notably decreased by all the compounds in both cell lines. On the other hand, Bax levels were increased by all the compounds in HCT15, although only slightly by Q. Bax was not detected in CO115, which is in accordance with a previous report [28] .
In addition, the possible involvement of the JNK and p38 pathways on the induction of apoptosis by the test compounds and 5-FU was evaluated. The results show no eVect on phospho-JNK levels by Q, L, and 5-FU in neither of the cell lines (Fig. 4b) . In HCT15 cells, no eVect on phospho-p38 levels was observed by the Xavonoids and 5-FU, while in CO115 cells, Q and L slightly increased the levels of phospho-p38 (Fig. 4c) . STS signiWcantly induced phospho-JNK levels and decreased the expression of phospho-p38 in both cell lines.
Combination of Q and 5-FU: dependence on p53
Since a signiWcant enhancement of 5-FU-induced apoptosis was observed in CO115 p53-wt cells with Q, an eVect Results are presented as mean § SEM of at least 3 independent experiments. *P · 0.05, **P · 0.01, and ***P · 0.001 concomitant with a robust p53 induction, we further investigated this eVect. First, as shown in Fig. 5 , combination of Q and 5-FU in CO115 cells also remarkably increased the cleavage of caspase-3, caspase-9, and PARP and decreased the Bcl-2 expression, but no further induction of p53 was observed. These results indicate that the apoptosis enhancement of Q with 5-FU is at the mitochondrial caspase pathway.
To explore the involvement of p53 in the induction of apoptosis by Q and 5-FU, CO115 cells were depleted for p53 (around 80%) by siRNA. As shown in Fig. 6a , p53-depleted CO115 cells were signiWcantly resistant to apoptosis when incubated with Q or 5-FU. In addition, the synergy between Q and 5-FU on the induction of apoptosis was absent in the p53 knockdown cells.
The role of p53 in the induction of apoptosis by Q was further conWrmed by using two isogenic KRAS-activated HCT116 CRC cell lines, one p53-wt and the other with a complete knockout of p53 (p53-null). These cells were incubated with 5-FU or Q alone or with both in combination, at concentrations that induce signiWcant inhibition of cell proliferation without substantial necrotic death (as observed by the MTT assay; data not shown). HCT116 p53-wt cells were much more susceptible than HCT116 p53-null cells to apoptosis induced by Q and 5-FU (Fig. 6b) . As in CO115 (KRAS-wt), a synergy between Q and 5-FU in the induction of apoptosis was observed in the KRAS-mutated HCT116 p53-wt cells. (5-FU) is the pharmaceutical drug most commonly used in CRC chemotherapy; however, tumor cell resistance to this drug remains a signiWcant concern. Failure to induce apoptosis has been reported to reduce the eYcacy of 5-FU, particularly in tumors presenting MSI and/or mutant p53 [7, 13, 15] . Thus, new compounds are needed to use in combination with 5-FU in order to increase treatment eYcacy. In a previous paper, we reported that Q and L, two structurally related dietary Xavonoids, possess potential anticarcinogenic eVects in two MSI-resistant CRC cell lines, HCT15 and CO115, through inhibition of PI3K/ Akt and MAPK/ERK pathways [24] . Inhibitory eVects on these two pathways have showed to contribute to an induction of apoptosis and to sensitize to chemotherapeutic drugs [29] [30] [31] [32] [33] . Here, we tested these Xavonoids in combination with 5-FU and an enhancement of apoptosis was found. HCT15 and CO115 cell lines showed diVerent susceptibilities to 5-FU. As expected, HCT15 cells, harboring a p53 mutation, were more resistant to 5-FU than CO115 cells (wt for p53). Q (in HCT15 cells) and L (in both cell lines) in combination with 5-FU showed to increase apoptosis additively. A signiWcant potentiation of apoptosis induction was detected when treating CO115 p53-wt cells with Q and 5-FU, which indicates a synergy between these two compounds in CO115. The eVect on apoptosis of this combination was even more pronounced than that of a 100 times higher concentration of 5-FU when tested alone.
Discussion
5-Fluorouracil
In CO115 cells, we observed that the caspase inhibitor zVAD totally abrogated apoptosis induction by Q and L, which was in agreement with the expression of apoptoticassociated molecular markers, such as cleaved (activated) caspase-9 and caspase-3 as well as a decrease in Bcl-2 expression. These results indicated that Q and L induce apoptosis via caspase-dependent pathway in CO115 cells with a contribution of the mitochondrial pathway. Even though CO115 cells do not express Bax, apoptosis induction mediated by mitochondria occurs possibly through interaction with the pro-apoptotic protein Bak. The induction of apoptosis by 5-FU in these cells was low, but also caspase dependent. A remarkable synergy was found for the co-incubation of Q with 5-FU in CO115. In these cells, Q showed a more dramatic induction of p53 compared with L, indicating a possible implication of p53 in the synergy observed between Q and 5-FU in CO115. The co-incubation of Q with 5-FU also remarkably enhanced the cleavage of caspase 9, caspase 3, and PARP as well as decreased Bcl-2 levels, compared with each of the compounds alone, suggesting the involvement of the apoptotic mitochondrial pathway in the synergy observed for Q and 5-FU in CO115. This synergy was not observed for HCT15 (p53 mutated) cells, which corroborates the dependence of Q on p53 for the observed eVect.
In order to elucidate the dependence of the apoptosis induced by Q and 5-FU on p53, p53 expression was decreased by siRNA in CO115 cells. A phenotype more resistant to apoptosis was observed, and interestingly, the synergy between Q and 5-FU observed in control cells (transfected cells with no p53 silencing) was lost in CO115 cells after p53 knockdown. This dependence on p53 was further conWrmed using two isogenic MSI (KRAS-mutated) HCT116 cell lines. HCT116 p53-null cells showed a smaller apoptotic response to Q and 5-FU as compared with HCT116 p53-wt cells. Furthermore, apoptosis was signiWcantly enhanced when Q was combined with 5-FU only in HCT116 p53-wt cells, with the eVect being lost in the HCT116 p53-null cells. These results clearly indicate that Q induces apoptosis through the modulation of p53 and that this contributes to the synergy found for the combination with 5-FU in p53-wt CRC cells. Moreover, the dependence on p53 in the induction of apoptosis by Q seems to be independent of KRAS status, since this eVect was observed in CO115 KRAS-wt cell line as well as in the KRAS-mutant HCT116 cell line.
The resistance to 5-FU of TP53-deWcient CRC cells has previously been reported [15] . In some studies, this chemotherapeutic drug has been combined with natural compounds in diVerent genetic backgrounds, such as triptolide and rosiglitazone in microsatellite stable (MSS) CRC cell lines [34, 35] and notoginseng and its ginsenosides in MSI HCT116 p53-wt cells [36] , with favorable outcome. Moreover, luteolin was also demonstrated by others [37] to increase the apoptotic eVect of the chemotherapeutic drug, cisplatin, in a p53-dependent manner in diVerent cell types including in HCT116 p53-wt cells.
In HCT15 cells, zVAD did not inhibit apoptosis induced by any of the test compounds or the reference inducer STS. The lack of caspase-dependent apoptosis was corroborated by the absence of cleaved caspase-9 and caspase-3 when these cells were incubated with Q, L, or 5-FU. Although all compounds induced p53 expression in HCT15 cells, alteration in the expression of p53 protein is not expected to be of functional signiWcance for apoptosis in this p53-mutated cell line. Also, Bax expression levels increased and Bcl-2 decreased in response to test compounds that, however, did not activate apoptosis through mitochondrial caspase pathway in HCT15 cells. JNK and p38 pathways seem not to be involved in the induction of apoptosis in these cells, contrarily to what was observed with CO115 where the p38 pathway may contribute to the induction of apoptosis. An induction of JNK phosphorylation and a decrease in p38 expression were observed for STS in both cell lines. The activation of JNK by STS has been reported in breast cancer cells [38] , but the eVect of this compound on these two stress-activated kinases in CRC is not well established.
CRC MSI patients require treatment alternatives that enhance 5-FU responsiveness and would gain from customized treatment modalities based on p53 status. The present study shows the potential applicability of Q and L in the enhancement of the apoptotic eVects of 5-FU in MSI CRC cells. Of particular relevance, Q shows the ability to cooperate with 5-FU to potentiate the induction of apoptosis in p53 wt colorectal cancer cells through p53 signaling. 
